Trelagliptin succinate
Trelagliptin succinate (SYR-472 succinate) is a long-acting DPP-4 inhibitor developed for type 2 diabetes management. It is used in research to study incretin hormone stabilization and glycemic control in both in vitro enzymatic assays and in vivo diabetic animal models.
Product Specifications
CAS Number
1029877-94-8
Product Name Alternative
Diabete, Dipeptidyl Peptidase, DPP, DPP4, DPP-4, Anti-diabetic, inhibit, Inhibitor, mellitus, glycemic, Zafatek, SYR472, SYR-472, SYR472 Succinate, SYR-472 Succinate, SYR-472 succinate, SYR 472, SYR 472 Succinate, Trelagliptin, Trelagliptin succinate, Trelagliptin Succinate
Field of Research
Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.00% (May vary between batches)
Solubility
DMSO:55 mg/mL (115.68 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.21 mM)
Smiles
Cn1c (=O) cc (n (c1=O) Cc1c (ccc (c1) F) C#N) N1CCC[C@H] (C1) N.C (CC (=O) O) C (=O) O
Molecular Formula
C22H26FN5O6
Molecular Weight
475.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog